A database of genetic information of more than 270 cancer models, encompassing 25 different childhood cancers, has just been made publicly available. Children’s Cancer Institute contributed 90 leukaemia models to this global effort.
We presented exciting results from preclinical drug testing at a cancer conference this week in the US.
Planning on a PhD in biomedical research? We have four prestigious scholarships on offer for the best and brightest.
A test that makes drug-resistant leukaemia cells glow could reveal a brighter future for developing new leukaemia therapies.
Venetoclax has been approved by the Australian Therapeutics Goods Administration (TGA) to treat an adult leukaemia. Could it one day treat childhood leukaemia?
Children’s cancers are a focus for three priority-driven research grants announced this week by Cancer Australia.
A study published this month shows venetoclax could successfully target high-risk leukaemia subtypes in infants or children. Clinical trials are planned.
Find out about the most common childhood cancer, leukaemia, and the progress medical research is making in the search for a cure.